Surgical outcomes for robotic-assisted laparoscopic myomectomy compared to abdominal myomectomy

Sangha, Roopina; Eisenstein, David; George, Ajith; Munkarah, Adnan; Wegienka, Ganesa

doi:10.1007/s11701-010-0213-z

Cited by 11 publications

(23 citation statements)

References 11 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The mean age of the participants was comparable with other studies [18][19][20][21]. Additionally, our results show that the mean BMI was slightly higher (27.98 ± 5.87) than that in the study by Nash (26.50 ± 6.16) [20].…”

Section: Discussionsupporting

confidence: 88%

“…Our study showed comparable results with other studies in terms of length of hospital stay. The median length of stay was 3.00 days while Barakat, Chang, and Sangha also showed the same results [17][18][19].…”

Section: Discussionsupporting

confidence: 52%

“…On the other hand, we observed that estimated blood loss (EBL) was twice as high compared to the previous studies mentioned [17][18]. Our study demonstrated an EBL with a median of 500 mL as compared to 200 mL in Barakat, 200 mL in Sangha, and 150 mL in Chang [17][18][19]. The reason for the high value in our study is that one of our patients lost 3000 mL in the procedure, and six procedures also reported a 2000 mL loss, which led to the high values in our analysis.…”

Section: Discussioncontrasting

confidence: 46%

“…Furthermore, postoperative complications were observed in 26 cases (12.20%) with bleeding being the most common (17, 65%). This is quite high as compared with those in the Barakat and Sangha studies, which only reported one postoperative complication case each [17,19]. These results can be explained by assessing the co-morbidities related to the cases complicated.…”

Section: Discussionmentioning

confidence: 57%

“…In the current study, we found that the median duration of the surgery is 92 min. Compared to other studies, this was higher in Barakat, Chang, and Sangha, with 126 min, 120 min, and 127.5 min, respectively [17][18][19]. The time from the incision to closure is defined as actual surgical time.…”

Section: Discussionmentioning

confidence: 85%

See 4 more Smart Citations

Intraoperative and Postoperative Complications Following Open, Laparoscopic, and Hysteroscopic Myomectomies in Saudi Arabia

Alharbi

Alshadadi

Alobisi

et al. 2020

Cureus

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 88%

Section: Discussionsupporting

confidence: 52%

Section: Discussioncontrasting

confidence: 46%

Section: Discussionmentioning

confidence: 57%

Section: Discussionmentioning

confidence: 85%

See 3 more Smart Citations

Intraoperative and Postoperative Complications Following Open, Laparoscopic, and Hysteroscopic Myomectomies in Saudi Arabia

Alharbi

Alshadadi

Alobisi

et al. 2020

Cureus

View full text Add to dashboard Cite

Robotic‐assisted laparoscopic versus abdominal and laparoscopic myomectomy: A systematic review and meta‐analysis

Chen,

Ma,

Yang

et al. 2024

Intl J Gynecology & Obste

View full text Add to dashboard Cite

BackgroundMyomectomy is the preferred treatment for women with uterine fibroids and fertility requirements. There are three modalities are used in clinical practice for myomectomy: abdominal myomectomy (AM), laparoscopic myomectomy (LM), and robot‐assisted laparoscopic myomectomy (RLM).ObjectivesTo compare the perioperative and postoperative outcomes of RLM, AM, and LM.Search StrategyWe searched PubMed, Web of Science, Embase, and Clinical Trials for relevant literature published between January 2000 and January 2023.Selection CriteriaWe included all studies reporting peri‐ and postoperative outcomes of myomectomy in patients with uterine myomas. Surgical treatments were classified as RLM, LM, or AM.Data Collection and AnalysisTwo or more authors selected studies independently, assessed risk of bias, and extracted data. We derived mean difference (MD) or odds ratio (OR) with 95% confidence intervals (CIs) for each outcome, subgrouping trials by the patient characteristics and myoma characteristics. We used the I2 statistic to quantify heterogeneity and the random‐effects model for meta‐analysis when appropriate. We used the funnel plot to assess the publication bias.Main ResultsA total of 32 studies with 6357 patients were included, of which 1982 women had undergone RLM. The operating time was significantly longer (MD = 43.58, 95% confidence interval [CI]: 25.22–61.93, P < 0.001), and the incidence of cesarean section after myomectomy was significantly lower (OR = 0.27, 95% CI: 0.10–0.78, P = 0.02) in RLM than in LM. Compared with AM, the operation time, blood loss, blood transfusion rate, complication rate, total cost, length of hospital stay, and pregnancy rate of patients with RLM were significantly different.ConclusionsThe safety and effectiveness of RLM are superior to those of AM but inferior to those of LM.

show abstract

Recurrence after robotic myomectomy: is it associated with use of GnRH agonist?

et al. 2016

View full text Add to dashboard Cite

Gonadotropin-releasing hormone (GnRH) agonist therapy is used before myomectomy to decrease the size of the fibroids, but its association with fibroid recurrence postoperatively remains unsettled. We undertook a retrospective study of robotic-assisted myomectomy (RM) patients at our academic medical center to determine symptomatic recurrence and reoperation rates in those who did versus did not receive preoperative GnRH therapy. Only patients, who had their index myomectomy at least 2 years prior to the chart review, were included in this study. Of 118 RM patients identified between January 2005 and December 2009, 17 patients (14.4 %) had symptomatic recurrence as early as 5 months to as late as 30 months postoperatively. The symptomatic recurrence group had significantly higher preoperative GnRH use (35 vs 9 % non-recurrence; p = 0.009). A total of 7.6 % of all patients underwent reoperation. GnRH agonist use was significantly higher in the reoperation group (56 vs 9 % no reoperation; p = 0.002). Cavity entry during the initial surgery was also more frequent in the reoperation group (56 vs 20 %; p = 0.030), whereas the presence of multiple fibroids, size of the largest leiomyoma, and uterine volume were not statistically different between groups. Our study is among the earliest to report RM reoperation rates in patients receiving preoperative GnRH therapy, showing that the role of GnRH agonist therapy to shrink myomas may not be beneficial when measured against risk of disease recurrence.

show abstract

Surgical outcomes for robotic-assisted laparoscopic myomectomy compared to abdominal myomectomy

Cited by 11 publications

References 11 publications

Intraoperative and Postoperative Complications Following Open, Laparoscopic, and Hysteroscopic Myomectomies in Saudi Arabia

Intraoperative and Postoperative Complications Following Open, Laparoscopic, and Hysteroscopic Myomectomies in Saudi Arabia

Robotic‐assisted laparoscopic versus abdominal and laparoscopic myomectomy: A systematic review and meta‐analysis

Recurrence after robotic myomectomy: is it associated with use of GnRH agonist?

Contact Info

Product

Resources

About